(Q36011784)

11 August 2017

1 reference

title

Exploiting T cell receptor genes for cancer immunotherapy (English)

1 reference

11 August 2017

1 reference

S Xue

1

1 reference

11 August 2017

R Gillmore

2

1 reference

11 August 2017

A Downs

3

1 reference

11 August 2017

A Tsallios

4

1 reference

11 August 2017

A Holler

5

1 reference

11 August 2017

L Gao

6

1 reference

11 August 2017

V Wong

7

1 reference

11 August 2017

E Morris

8

1 reference

11 August 2017

H J Stauss

9

1 reference

11 August 2017

publication date

1 February 2005

1 reference

Clinical and Experimental Immunology

11 August 2017

published in

1 reference

11 August 2017

volume

139

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

167-172

1 reference

Progress in human tumour immunology and immunotherapy

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Immunotherapy with CTLs restricted by nonself MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

The MHC reactivity of the T cell repertoire prior to positive and negative selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

An epithelial cell line that can stimulate alloproliferation of resting CD4+ T cells, but not after IFN-gamma stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02715.X

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

T lymphocyte-endothelial cell interactions.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Retroviral transfer of T-cell receptor genes produces cells with a broad range of lytic activity

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Renaissance of cancer therapeutic antibodies

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Antigen presentation by parenchymal cells: a route to peripheral tolerance?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809284

Safety of retroviral gene marking with a truncated NGF receptor

14 November 2018

1 reference

12 December 2020

Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region

1 reference

12 December 2020

Self tolerance is H–2-restricted

1 reference

12 December 2020

Evidence from in vitro studies that tolerance to self antigens is MHC-restricted

1 reference

12 December 2020

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

12 December 2020

Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis

1 reference

12 December 2020

Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity

1 reference

12 December 2020

Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease

1 reference

12 December 2020

Immunotherapy through TCR gene transfer

1 reference

12 December 2020

10.1111/J.1365-2249.2005.02715.X

Identifiers

DOI

1 reference

11 August 2017

0 references

1 reference